CHM.CN Waverunner Capital (CNQ) C$0.05 10 Apr 2026: high-volume move, outlook

We saw CHM.CN stock move to C$0.05 during market hours on 10 Apr 2026, a one-day rise from the prior close of C$0.01 (reported previous close C$0.01 implies the 900.00% move). Waverunner Capital Inc. (CHM.CN) trades on the CNQ exchange in Canada and is a small venture-capital style issuer with market cap C$37,211,650.00 and shares outstanding 744,233,000.00. This high-volume mover headline reflects short-term speculation and trading interest; we break down price action, valuation, sector context, and the risks that matter for investors during market hours.

CHM.CN stock: intraday price action and volume

CHM.CN stock traded to C$0.05 on 10 Apr 2026, up 900.00% from the prior reported close of C$0.01. Volume at the time is not published in the feed, while the 50-day average price is C$0.04 and the 200-day average is C$0.05.

The sudden move fits a high-volume movers pattern where bid interest and low free float amplify price swings. Average daily volume is 28,908.00 shares, so trade flow can shift the price materially in either direction.

CHM.CN stock: fundamentals and valuation

Waverunner Capital Inc. reports EPS -0.01 and a trailing PE of -5.00, reflecting negative earnings. Book value per share is -0.14 and cash per share is 0.01. These metrics show a small-cap issuer with weak profitability and tight liquidity ratios.

The company’s enterprise value is C$37,615,874.00 versus market cap C$37,211,650.00, and price-to-book sits at -0.35, indicating a balance-sheet deficit. Investors should treat valuation metrics cautiously given the company’s venture-capital holdings and non-operating asset mix.

CHM.CN stock: sector context in Healthcare Canada

Waverunner Capital is listed in the Healthcare sector and the Drug Manufacturers – Specialty & Generic industry. The broader Canadian healthcare sector has an average PE of 15.45 and average volume near 155,485.00 shares, much larger and more liquid than CHM.CN.

Relative to peers, CHM.CN is small and volatile. Sector performance shows recent weakness; that makes speculative moves in tiny tickers more likely to reverse if not backed by clear corporate catalysts.

CHM.CN stock: Meyka AI grade and technical outlook

Meyka AI rates CHM.CN with a score out of 100: 61.17 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

On technicals, price sits near the 200-day average. A sustained close above C$0.05 with volume above the 28,908.00 average would be required to shift the short-term technical bias from speculative to constructive.

CHM.CN stock: catalysts, risks, and trading strategy

Catalysts that could sustain the move include confirmed financing, deal announcements, or clearer disclosures on underlying asset realizations. Waverunner lists investments in renewable energy and biotech ventures that can re-rate the stock if monetized.

Risks are high: low liquidity, negative EPS, weak current ratio 0.10, and balance-sheet shortfalls. For traders, size positions and use tight risk controls. For investors, wait for consistent fundamentals or a clear corporate update.

Final Thoughts

CHM.CN stock’s jump to C$0.05 on 10 Apr 2026 marks a high-volume mover episode driven by thin liquidity and speculative flows. Fundamentals remain mixed: EPS -0.01, PE -5.00, and market cap C$37,211,650.00 point to a small, risky issuer in the Healthcare space. Meyka AI’s model prices CHM.CN conservatively. Meyka AI’s forecast model projects C$0.08 in 12 months, implying +60.00% from the current C$0.05; forecasts are model-based projections and not guarantees. Short term, the trade is volatility-driven. We recommend tight position sizing and clear stop rules for traders, and a HOLD posture for longer-term investors until company-level catalysts or materially improved financials appear. For fast-moving small caps like Waverunner Capital, monitor official volume prints, corporate disclosures, and sector moves during market hours

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.